$208.93
0.08%
NYSE, Sep 25, 04:00 pm EDT. Closed.
ISIN
IE00BFY8C754
Symbol
STE

Steris Target price 2026 - Analyst rating & recommendation

Steris Classifications & Recommendation

Buy
69%
Hold
31%

Steris Price Target

Target Price $275.40
Price $208.93
Potential
Number of Estimates 11
11 Analysts have issued a price target Steris 2027 . The average Steris target price is $275.40. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 16 analysts: 11 Analysts recommend Steris to buy, 5 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Steris stock has an average upside potential 2027 of . Most analysts recommend the Steris stock at Purchase.

Sales and Margin forecast 2027, 2028 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Mar '26 2027
Estimates
Revenue Billion $ 5.94 6.44
8.73% 8.43%
EBITDA Margin 26.93% 28.78%
1.53% 6.87%
Net Margin 13.18% 17.09%
17.06% 29.67%

13 Analysts have issued a sales forecast Steris 2027 . The average Steris sales estimate is

$6.4b
unlock
. This is
6.60% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$6.7b 11.17%
unlock
, the lowest is
$6.2b 3.02%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2026 $5.9b 8.73%
2027
$6.4b 8.43%
unlock
2028
$6.8b 6.37%
unlock
2029
$7.3b 6.31%
unlock
2030
$7.7b 5.78%
unlock
2031
$8.2b 5.92%
unlock

10 Analysts have issued an Steris EBITDA forecast 2027. The average Steris EBITDA estimate is

$1.9b
unlock
. This is
13.04% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$2.2b 32.82%
unlock
, the lowest is
$1.7b 1.81%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2026 $1.6b 10.38%
2027
$1.9b 15.85%
unlock
2028
$2.0b 7.78%
unlock
2029
$2.1b 6.46%
unlock

EBITDA Margin

2026 26.93% 1.53%
2027
28.78% 6.87%
unlock
2028
29.16% 1.32%
unlock
2029
29.20% 0.14%
unlock

13 Steris Analysts have issued a net profit forecast 2027. The average Steris net profit estimate is

$1.1b
unlock
. This is
36.66% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$1.2b 43.31%
unlock
, the lowest is
$1.0b 29.36%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 $782m 27.28%
2027
$1.1b 40.64%
unlock
2028
$1.2b 9.61%
unlock
2029
$1.3b 9.62%
unlock
2030
$1.4b 7.41%
unlock
2031
$1.5b 6.45%
unlock

Net Margin

2026 13.18% 17.06%
2027
17.09% 29.67%
unlock
2028
17.62% 3.10%
unlock
2029
18.16% 3.06%
unlock
2030
18.44% 1.54%
unlock
2031
18.54% 0.54%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2031

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Mar '26 2027
Estimates
Earnings Per Share $ 7.93 11.28
27.90% 42.24%
P/E 18.50
EV/Sales 3.38

13 Analysts have issued a Steris forecast for earnings per share. The average Steris EPS is

$11.28
unlock
. This is
37.23% higher
unlock
than earnings per share in the financial year 2026. The highest EPS forecast is
$11.83 43.92%
unlock
, the lowest is
$10.68 29.93%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 $7.93 27.90%
2027
$11.28 42.24%
unlock
2028
$12.37 9.66%
unlock
2029
$13.56 9.62%
unlock
2030
$14.56 7.37%
unlock
2031
$15.50 6.46%
unlock

P/E ratio

Current 25.40 33.23%
2027
18.50 27.16%
unlock
2028
16.88 8.76%
unlock
2029
15.40 8.77%
unlock
2030
14.33 6.95%
unlock
2031
13.47 6.00%
unlock

Based on analysts' sales estimates for 2027, the Steris stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.61 23.03%
2027
3.38 6.32%
unlock
2028
3.18 5.99%
unlock
2029
2.99 5.94%
unlock
2030
2.83 5.47%
unlock
2031
2.67 5.59%
unlock

P/S ratio

Current 3.37 23.34%
2027
3.16 6.19%
unlock
2028
2.97 5.99%
unlock
2029
2.80 5.94%
unlock
2030
2.64 5.47%
unlock
2031
2.50 5.59%
unlock

Current Steris Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Piper Sandler
Locked
➜
Locked
Locked Aug 07 2026
UBS
Locked
➜
Locked
Locked Aug 07 2026
UBS
Locked
➜
Locked
Locked Jul 28 2026
Keybanc
Locked
➜
Locked
Locked May 13 2026
Keybanc
Locked
➜
Locked
Locked Jul 22 2025
Morgan Stanley
Locked
➜
Locked
Locked Jul 15 2025
Jefferies
Locked
➜
Locked
Locked May 29 2025
Analyst Rating Date
Locked
Piper Sandler:
Locked
➜
Locked
Aug 07 2026
Locked
UBS:
Locked
➜
Locked
Aug 07 2026
Locked
UBS:
Locked
➜
Locked
Jul 28 2026
Locked
Keybanc:
Locked
➜
Locked
May 13 2026
Locked
Keybanc:
Locked
➜
Locked
Jul 22 2025
Locked
Morgan Stanley:
Locked
➜
Locked
Jul 15 2025
Locked
Jefferies:
Locked
➜
Locked
May 29 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today